Titleist Asset Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Titleist Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.28 - $1.16 $92,612 - $383,679	-330,758 Reduced 12.72%	2,268,824 $758 Million
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $26,042 - $41,028	-24,568 Reduced 0.94%	2,599,582 $3.02 Billion
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $63,800 - $90,636	50,635 Added 1.97%	2,624,150 $4.43 Billion
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $66,381 - $104,726	41,231 Added 1.63%	2,573,515 $4.66 Billion
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $41,841 - $71,570	36,703 Added 1.47%	2,532,284 $4.71 Billion
Q1 2023 May 18, 2023	BUY	$1.2 - $2.19 $2.99 Million - $5.47 Million	2,495,581 New	2,495,581 $3.32 Billion

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Titleist Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Titleist Asset Management, LLC with notifications on news.